O	O	0	12	Reactivation	Reactivation	B-NP	NN	O	0	ROOT	O
O	O	13	15	of	of	B-PP	IN	O	1	NMOD	O
O	O	16	22	Kaposi	Kaposi	B-NP	NNP	O	4	NMOD	O
O	O	22	23	'	'	B-NP	POS	O	6	NMOD	O
O	O	23	24	s	s	I-NP	NN	O	6	NMOD	O
O	O	25	32	sarcoma	sarcoma	I-NP	NN	O	2	PMOD	O
O	O	32	33	-	-	B-VP	HYPH	O	6	NMOD	O
O	O	33	43	associated	associate	B-NP	VBN	O	10	NMOD	O
O	O	44	55	herpesvirus	herpesvirus	I-NP	NN	O	10	NMOD	O
O	O	56	65	infection	infection	I-NP	NN	O	7	OBJ	O
O	O	66	70	from	from	B-PP	IN	O	10	NMOD	O
O	O	71	78	latency	latency	B-NP	NN	O	11	PMOD	O
O	O	79	81	by	by	B-PP	IN	O	10	NMOD	O
O	O	82	92	expression	expression	B-NP	NN	O	13	PMOD	O
O	O	93	95	of	of	B-PP	IN	O	14	NMOD	O
O	O	96	99	the	the	B-NP	DT	O	19	NMOD	O
T1	B-Protein	100	103	ORF	ORF	I-NP	NN	B-protein	19	NMOD	B-protein
T1	I-Protein	104	106	50	50	I-NP	CD	I-protein	19	NMOD	I-protein
T1	I-Protein	107	121	transactivator	transactivator	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	121	122	,	,	O	,	O	22	P	O
O	O	123	124	a	a	B-NP	DT	O	22	NMOD	O
O	O	125	132	homolog	homolog	I-NP	NN	O	15	PMOD	O
O	O	133	135	of	of	B-PP	IN	O	22	NMOD	O
O	O	136	139	the	the	B-NP	DT	O	27	NMOD	O
T2	B-Protein	140	143	EBV	EBV	I-NP	NN	B-protein	27	NMOD	B-protein
T2	I-Protein	144	145	R	R	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	146	153	protein	protein	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	153	154	.	.	O	.	O	1	P	O

O	O	156	162	Kaposi	Kaposi	B-NP	NNP	O	2	NMOD	O
O	O	162	163	'	'	B-NP	POS	O	4	NMOD	O
O	O	163	164	s	s	I-NP	NN	O	4	NMOD	O
O	O	165	172	sarcoma	sarcoma	I-NP	NN	O	10	NMOD	O
O	O	173	174	(	(	O	(	O	7	DEP	O
O	O	174	176	KS	KS	B-NP	NN	O	7	DEP	O
O	O	176	177	)	)	O	)	O	4	NMOD	O
O	O	177	178	-	-	O	HYPH	O	4	P	O
O	O	178	188	associated	associate	B-NP	VBN	O	10	NMOD	O
O	O	189	200	herpesvirus	herpesvirus	I-NP	NN	O	17	NMOD	O
O	O	201	202	(	(	O	(	O	13	DEP	O
O	O	202	206	KSHV	KSHV	B-NP	NN	O	13	DEP	O
O	O	206	207	)	)	O	)	O	10	NMOD	O
O	O	207	208	,	,	O	,	O	17	P	O
O	O	209	211	or	or	O	CC	O	17	NMOD	O
O	O	212	217	human	human	B-NP	JJ	O	17	NMOD	O
O	O	218	229	herpesvirus	herpesvirus	I-NP	NN	O	20	SUB	O
O	O	230	231	8	8	I-NP	CD	O	17	NMOD	O
O	O	231	232	,	,	O	,	O	17	P	O
O	O	233	235	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	236	237	a	a	B-NP	DT	O	23	NMOD	O
O	O	238	250	lymphotropic	lymphotropic	I-NP	JJ	O	23	NMOD	O
O	O	251	256	virus	virus	I-NP	NN	O	20	PRD	O
O	O	257	265	strongly	strongly	B-VP	RB	O	25	VMOD	O
O	O	266	272	linked	link	I-VP	VBN	O	23	NMOD	O
O	O	273	275	to	to	B-PP	TO	O	25	VMOD	O
O	O	276	283	several	several	B-NP	JJ	O	28	NMOD	O
O	O	284	288	AIDS	AIDS	I-NP	NN	O	31	NMOD	O
O	O	288	289	-	-	B-NP	HYPH	O	31	P	O
O	O	289	296	related	relate	I-NP	VBN	O	31	NMOD	O
O	O	297	306	neoplasms	neoplasm	I-NP	NNS	O	26	PMOD	O
O	O	306	307	.	.	O	.	O	20	P	O

O	O	308	311	The	The	B-NP	DT	O	3	NMOD	O
O	O	312	319	primary	primary	I-NP	JJ	O	3	NMOD	O
O	O	320	329	reservoir	reservoir	I-NP	NN	O	6	SUB	O
O	O	330	332	of	of	B-PP	IN	O	3	NMOD	O
O	O	333	342	infection	infection	B-NP	NN	O	4	PMOD	O
O	O	343	351	consists	consist	B-VP	VBZ	O	0	ROOT	O
O	O	352	354	of	of	B-PP	IN	O	6	VMOD	O
O	O	355	363	latently	latently	B-NP	RB	O	9	AMOD	O
O	O	364	372	infected	infected	I-NP	JJ	O	16	NMOD	O
O	O	373	374	B	B	I-NP	NN	B-cell_type	11	NMOD	B-cell_type
O	O	375	386	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	16	NMOD	I-cell_type
O	O	387	390	and	and	O	CC	O	16	NMOD	O
O	O	391	399	possibly	possibly	B-ADVP	RB	O	14	NMOD	O
O	O	400	405	other	other	B-NP	JJ	O	16	NMOD	O
O	O	406	417	mononuclear	mononuclear	I-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	418	423	cells	cell	I-NP	NNS	I-cell_type	7	PMOD	I-cell_type
O	O	423	424	.	.	O	.	O	6	P	O

O	O	425	430	Viral	Viral	B-NP	JJ	O	2	NMOD	O
O	O	431	443	reactivation	reactivation	I-NP	NN	O	6	NMOD	O
O	O	444	448	from	from	B-PP	IN	O	2	NMOD	O
O	O	449	456	latency	latency	B-NP	NN	O	3	PMOD	O
O	O	457	460	and	and	I-NP	CC	O	6	NMOD	O
O	O	461	467	spread	spread	I-NP	NN	O	11	SUB	O
O	O	468	472	from	from	B-PP	IN	O	6	NMOD	O
O	O	473	477	this	this	B-NP	DT	O	10	NMOD	O
O	O	478	486	lymphoid	lymphoid	I-NP	JJ	O	10	NMOD	O
O	O	487	496	reservoir	reservoir	I-NP	NN	O	7	PMOD	O
O	O	497	499	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	500	510	presumably	presumably	I-VP	RB	O	11	VMOD	O
O	O	511	519	required	require	I-VP	VBN	O	11	VC	O
O	O	520	523	for	for	B-PP	IN	O	13	VMOD	O
O	O	524	535	development	development	B-NP	NN	O	14	PMOD	O
O	O	536	538	of	of	B-PP	IN	O	15	NMOD	O
O	O	539	550	nonlymphoid	nonlymphoid	B-NP	JJ	O	18	NMOD	O
O	O	551	557	tumors	tumor	I-NP	NNS	O	16	PMOD	O
O	O	558	562	like	like	B-PP	IN	O	18	NMOD	O
O	O	563	565	KS	KS	B-NP	NN	O	19	PMOD	O
O	O	565	566	.	.	O	.	O	11	P	O

O	O	567	571	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	572	574	we	we	B-NP	PRP	O	3	SUB	O
O	O	575	579	show	show	B-VP	VBP	O	0	ROOT	O
O	O	580	584	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	585	596	deregulated	deregulate	B-NP	VBN	O	6	NMOD	O
O	O	597	607	expression	expression	I-NP	NN	O	4	SBAR	O
O	O	608	610	of	of	B-PP	IN	O	6	NMOD	O
O	O	611	612	a	a	B-NP	DT	O	11	NMOD	O
O	O	613	619	single	single	I-NP	JJ	O	11	NMOD	O
T4	B-Entity	620	625	viral	viral	I-NP	JJ	B-DNA	11	NMOD	B-DNA
T4	I-Entity	626	630	gene	gene	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	630	631	,	,	O	,	O	13	P	O
T3	B-Protein	632	635	ORF	ORF	B-NP	NN	B-DNA	7	PMOD	B-DNA
T3	I-Protein	636	638	50	50	I-NP	CD	I-DNA	13	NMOD	I-DNA
O	O	638	639	,	,	O	,	O	13	P	O
O	O	640	645	which	which	B-NP	WDT	O	13	NMOD	O
O	O	646	653	encodes	encode	B-VP	VBZ	O	16	SBAR	O
O	O	654	655	a	a	B-NP	DT	O	19	NMOD	O
O	O	656	670	transactivator	transactivator	I-NP	NN	O	17	OBJ	O
O	O	671	675	able	able	B-ADJP	JJ	O	19	NMOD	O
O	O	676	678	to	to	B-VP	TO	O	23	VMOD	O
O	O	679	690	selectively	selectively	I-VP	RB	O	23	VMOD	O
O	O	691	701	upregulate	upregulate	I-VP	VB	O	20	AMOD	O
T5	B-Entity	702	709	delayed	delay	I-VP	VBN	O	23	VC	O
T5	I-Entity	709	710	-	-	O	HYPH	B-DNA	28	NMOD	B-DNA
T5	I-Entity	710	715	early	early	B-NP	JJ	I-DNA	28	NMOD	I-DNA
T5	I-Entity	716	721	viral	viral	I-NP	JJ	I-DNA	28	NMOD	I-DNA
T5	I-Entity	722	727	genes	gene	I-NP	NNS	I-DNA	24	OBJ	I-DNA
O	O	727	728	,	,	O	,	O	32	P	O
O	O	729	737	suffices	suffice	B-NP	NNS	O	32	SUB	O
O	O	738	740	to	to	B-VP	TO	O	32	VMOD	O
O	O	741	748	disrupt	disrupt	I-VP	VB	O	28	NMOD	O
O	O	749	756	latency	latency	B-NP	NN	O	32	OBJ	O
O	O	757	760	and	and	O	CC	O	6	VMOD	O
O	O	761	767	induce	induce	B-VP	VB	O	6	NMOD	O
O	O	768	771	the	the	B-NP	DT	O	39	NMOD	O
T6	B-Entity	772	777	lytic	lytic	I-NP	JJ	B-DNA	39	NMOD	B-DNA
T6	I-Entity	778	782	gene	gene	I-NP	NN	I-DNA	39	NMOD	I-DNA
O	O	783	790	cascade	cascade	I-NP	NN	O	35	OBJ	O
O	O	791	793	in	in	B-PP	IN	O	35	VMOD	O
O	O	794	802	latently	latently	B-NP	RB	B-cell_type	44	NMOD	B-cell_type
O	O	803	811	infected	infected	I-NP	JJ	I-cell_type	44	NMOD	I-cell_type
O	O	812	813	B	B	I-NP	NN	I-cell_type	44	NMOD	I-cell_type
O	O	814	819	cells	cell	I-NP	NNS	I-cell_type	40	PMOD	I-cell_type
O	O	819	820	.	.	O	.	O	3	P	O

O	O	821	824	The	The	B-NP	DT	O	2	NMOD	O
O	O	825	839	identification	identification	I-NP	NN	O	6	SUB	O
O	O	840	842	of	of	B-PP	IN	O	2	NMOD	O
O	O	843	847	this	this	B-NP	DT	O	5	NMOD	O
O	O	848	852	gene	gene	I-NP	NN	O	3	PMOD	O
O	O	853	858	opens	open	B-VP	VBZ	O	0	ROOT	O
O	O	859	862	the	the	B-NP	DT	O	8	NMOD	O
O	O	863	866	way	way	I-NP	NN	O	6	OBJ	O
O	O	867	869	to	to	B-PP	TO	O	8	NMOD	O
O	O	870	877	studies	study	B-NP	NNS	O	9	PMOD	O
O	O	878	880	of	of	B-PP	IN	O	10	NMOD	O
O	O	881	884	the	the	B-NP	DT	O	14	NMOD	O
O	O	885	896	physiologic	physiologic	I-NP	JJ	O	14	NMOD	O
O	O	897	907	mechanisms	mechanism	I-NP	NNS	O	11	PMOD	O
O	O	908	919	controlling	control	B-VP	VBG	O	14	NMOD	O
O	O	920	931	reactvation	reactvation	B-NP	NN	O	15	OBJ	O
O	O	932	934	of	of	B-PP	IN	O	16	NMOD	O
O	O	935	939	KSHV	KSHV	B-NP	NN	O	17	PMOD	O
O	O	940	944	from	from	B-PP	IN	O	18	NMOD	O
O	O	945	952	latency	latency	B-NP	NN	O	19	PMOD	O
O	O	952	953	.	.	O	.	O	6	P	O

O	O	954	963	Copyright	Copyright	B-NP	NN	O	4	NMOD	O
O	O	964	968	1998	1998	I-NP	CD	O	4	NMOD	O
O	O	969	977	Academic	Academic	I-NP	NNP	O	4	NMOD	O
O	O	978	983	Press	Press	I-NP	NNP	O	0	ROOT	O
O	O	983	984	.	.	O	.	O	4	P	O
